TrialCancer medicine2018

Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling.

Rui Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.